Market Performance
- Cocrystal Pharma (COCP)
- Closing price 24 h period ending 08:04 AM Central Europe on Monday 26 th: USD 0.95.
- Share price increased 4.4 % during this period.
- Current market capitalization: USD 18.3 million.
- Current free float: 19.3 million shares.
- Turnover in the last 24 h: USD 41.3 k.
- 200‑day simple moving average: USD 1.10.
- 52‑week high: USD 2.03 (recorded 04 Feb 2026).
- 52‑week low: USD 0.76 (recorded 29 Jul 2026).
- Share price decline since the end of last month: ‑17.39 %.
Comparative Performance (Last 24 h)
| Stock | Ticker | % Change | Current Price | Market Capitalisation |
|---|---|---|---|---|
| Century Casinos | CNTY | ‑1.3 % | USD 0.76 | USD 21.4 million |
| Nexttrip | NTRP | +7.75 % | USD 1.39 | USD 21 million |
| Beeline | BLNE | ‑3.37 % | USD 0.66 | USD 21.7 million |
| Big Digital Energy | BGDE | ‑7.21 % | USD 3.86 | USD 21.9 million |
| Alset | AEI | ‑6.68 % | USD 0.56 | USD 21.8 million |
Company Overview
Cocrystal Pharma, Inc. is a biotechnology company headquartered in Tucker, United States. The company focuses on the development of novel antiviral therapeutics targeting hepatitis viruses, influenza viruses, and noroviruses. Cocrystal Pharma’s mission is to introduce innovative drugs that selectively target specific viral strains to improve patient outcomes. The company operates primarily within the health‑care sector and serves patients mainly in the United States. Cocrystal Pharma is listed on the Nasdaq stock exchange. Further information about its products and research can be found on its website: www.cocrystalpharma.com .